This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

18 Jul 2011

Valeant Acquires Ortho Dermatologics for $345M

The deal was Valeant's second planned dermatology acquisition announced in the past week.

Valeant Pharmaceuticals International, Inc. announced last Friday that the company signed an agreement to acquire the assets of the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc. (a J&J business) for $345 million.


The acquisition, which follows Valeant's purchase of Sanofi's Dermik unit early last week, includes prescription brands RETIN-A MICRO, ERTACZO, and RENOVA.  Total revenue for the product portfolio was approximately $150 million in 2010.  The transaction is subject to certain closing conditions and regulatory approvals and is expected to be accretive in 2011.


"With the combination of this transaction and other recently announced transactions, Valeant is well on its way to being one of the leading companies in dermatology," st

Related News